Insider trades
Stanley C. Erck, Director of Maxcyte MXCT, has filed 1 purchase and 5 sales on the open market. The latest trade was on 06/17.
Stanley C. Erck
Director
- Company
- Maxcyte MXCT
- First filing
- 23/06/23
- Trades
- 23 trades
- Buys / sales
- 1 / 5
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MaxcyteMXCT | Open-market buy | 25/08/13 | 25/08/13 | 100,000 sh | $1.37 | $137,000 | +33.5% |
MaxcyteMXCT | Open-market sale10b5-1 plan | 24/11/01 | 24/11/05 | 47,689 sh | $3.72 | $177,403.08 | −15.1% |
MXCT | Open-market sale10b5-1 plan | 24/10/01–24/10/02 | 24/10/02 | 47,689 sh2 trades | $3.75avg. | $178,751.93 | −15.1% |
MXCT | Open-market sale10b5-1 plan | 24/09/03–24/09/04 | 24/09/05 | 47,689 sh2 trades | $4.02avg. | $191,655.19 | −15.1% |